Market cap
$70.6M

Nutriband Inc. (NTRB) is an Industrial Specialties company listed on NASDAQ. In the last 30 days Quantisnow tracked 1 wire item for NTRB, including 1 press release or news item. The most recent was published Nov 17, 2026.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.

Financial highlights

Full financials
Revenue, TTM
$1.62M
Revenue growth
-37.3%
Net income, TTM
-$6.96M
Net margin
-430.4%
Cash
$3.42M

For the twelve months ended Jul 31, 2026, from SEC filings. Not investment advice.

News · 26 weeks12-75%
2026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 12026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 12026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 22026-09-13: 02026-09-20: 32026-09-27: 22026-10-04: 12026-10-11: 12026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 02026-11-15: 1
2026-05-242026-11-15
Mix1090d
  • Other7(70%)
  • SEC Filings1(10%)
  • Leadership1(10%)
  • Offering1(10%)
Activity · 52 weeks3029 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

NTRB FAQ

10 questions
  • What does Nutriband Inc. do?
    Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
  • What is the latest news on NTRB?
    In the last 30 days Quantisnow tracked 1 wire item for NTRB: 1 press release or news item. The most recent was published on November 17, 2026.
  • What is NTRB revenue?
    Nutriband Inc. (NTRB) reported $1.62M of revenue for the twelve months ended Jul 31, 2026. That is down 37.3% from the year before. Revenue for fiscal 2026 was $2.04M.
  • Is NTRB profitable?
    No. Nutriband Inc. reported a net loss of $6.96M for the twelve months ended Jul 31, 2026.
  • How much cash and debt does NTRB have?
    Nutriband Inc. reported $3.42M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does NTRB stock trade?
    Nutriband Inc. (NTRB) is listed on NASDAQ.
  • What sector and industry is NTRB in?
    Nutriband Inc. operates in the Health Care sector, Industrial Specialties industry.
  • What are analysts saying about NTRB?
    Nutriband Inc. has had 1 recent analyst action on file. The most recent action was from Noble Capital Markets: Outperform with a $13.00 price target on 2025-01-22. Recent price targets cluster around $13.00.
  • What companies are similar to NTRB?
    Notable peers in the same industry include ZBH (Zimmer Biomet Holdings Inc.), STE (STERIS plc (Ireland)), ALGN (Align Technology Inc.), EW (Edwards Lifesciences Corporation), ISRG (Intuitive Surgical Inc.). Compare NTRB side-by-side with any of them on Quantisnow.
  • How can I track NTRB on Quantisnow?
    Quantisnow aggregates Nutriband Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NTRB to receive live email and push alerts on every new disclosure.